Premium
Letter: persistence of anti‐infliximab antibodies after discontinuation of infliximab in patients with IBD – authors’ reply
Author(s) -
BenHorin S.,
Chowers Y.
Publication year - 2012
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/j.1365-2036.2012.05215.x
Subject(s) - infliximab , medicine , biosimilar , discontinuation , antibody , polyclonal antibodies , immunology , tumor necrosis factor alpha